Search

Ayaan A Alam

Examiner (ID: 3803)

Most Active Art Unit
1611
Art Unit(s)
1611
Total Applications
153
Issued Applications
27
Pending Applications
65
Abandoned Applications
61

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 1490010 [patent_doc_number] => 06417002 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-07-09 [patent_title] => 'Method for maintenance and selection of episomes' [patent_app_type] => B1 [patent_app_number] => 09/249585 [patent_app_country] => US [patent_app_date] => 1999-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 9 [patent_no_of_words] => 13411 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/417/06417002.pdf [firstpage_image] =>[orig_patent_app_number] => 09249585 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/249585
Method for maintenance and selection of episomes Feb 10, 1999 Issued
Array ( [id] => 1528741 [patent_doc_number] => 06479654 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-12 [patent_title] => 'Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF' [patent_app_type] => B1 [patent_app_number] => 09/244583 [patent_app_country] => US [patent_app_date] => 1999-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23393 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/479/06479654.pdf [firstpage_image] =>[orig_patent_app_number] => 09244583 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/244583
Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF Feb 3, 1999 Issued
09/230600 NOVEL LIPOLYTIC ENZYMES Jan 26, 1999 Abandoned
Array ( [id] => 1504709 [patent_doc_number] => 06465617 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Identification and characterization of a gene which protects cells from programmed cell death and uses therefor' [patent_app_type] => B1 [patent_app_number] => 09/233527 [patent_app_country] => US [patent_app_date] => 1999-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 23274 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465617.pdf [firstpage_image] =>[orig_patent_app_number] => 09233527 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/233527
Identification and characterization of a gene which protects cells from programmed cell death and uses therefor Jan 19, 1999 Issued
09/219698 TARGETED GENE TRANSFER USING G PROTEIN COUPLED RECEPTORS Dec 22, 1998 Abandoned
Array ( [id] => 1562348 [patent_doc_number] => 06362326 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-26 [patent_title] => '11 cby genomic sequence' [patent_app_type] => B1 [patent_app_number] => 09/218467 [patent_app_country] => US [patent_app_date] => 1998-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 1 [patent_no_of_words] => 12836 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/362/06362326.pdf [firstpage_image] =>[orig_patent_app_number] => 09218467 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/218467
11 cby genomic sequence Dec 21, 1998 Issued
Array ( [id] => 1546743 [patent_doc_number] => 06444870 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-09-03 [patent_title] => 'Methods for assessing the role of calcineurin immunosuppression and neurotoxicity' [patent_app_type] => B1 [patent_app_number] => 09/212868 [patent_app_country] => US [patent_app_date] => 1998-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31811 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/444/06444870.pdf [firstpage_image] =>[orig_patent_app_number] => 09212868 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/212868
Methods for assessing the role of calcineurin immunosuppression and neurotoxicity Dec 15, 1998 Issued
09/193834 METHODS OF CREATING CONSTRUCTS USEFUL FOR INTRODUCING SEQUENCES INTO EMBRYONIC STEM CELLS Nov 16, 1998 Abandoned
09/171802 GENE EXPRESSION IN MONOCYTES AND MACROPHAGES Oct 25, 1998 Abandoned
Array ( [id] => 1277166 [patent_doc_number] => 06641526 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-04 [patent_title] => 'Development of normal offspring from oocytes injected with freeze-dried spermatozoa' [patent_app_type] => B1 [patent_app_number] => 09/177391 [patent_app_country] => US [patent_app_date] => 1998-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8851 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/641/06641526.pdf [firstpage_image] =>[orig_patent_app_number] => 09177391 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/177391
Development of normal offspring from oocytes injected with freeze-dried spermatozoa Oct 22, 1998 Issued
Array ( [id] => 1338952 [patent_doc_number] => 06593463 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-07-15 [patent_title] => 'Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems' [patent_app_type] => B1 [patent_app_number] => 09/175684 [patent_app_country] => US [patent_app_date] => 1998-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 15 [patent_no_of_words] => 5140 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/593/06593463.pdf [firstpage_image] =>[orig_patent_app_number] => 09175684 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/175684
Modified MSP-1 nucleic acid sequences and methods for increasing MRNA levels and protein expression in cell systems Oct 19, 1998 Issued
Array ( [id] => 4343027 [patent_doc_number] => 06284539 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-04 [patent_title] => 'Method for generating dopaminergic cells derived from neural precursors' [patent_app_type] => 1 [patent_app_number] => 9/169309 [patent_app_country] => US [patent_app_date] => 1998-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 14611 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 96 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/284/06284539.pdf [firstpage_image] =>[orig_patent_app_number] => 169309 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/169309
Method for generating dopaminergic cells derived from neural precursors Oct 8, 1998 Issued
Array ( [id] => 1436273 [patent_doc_number] => 06355859 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-03-12 [patent_title] => 'Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease' [patent_app_type] => B1 [patent_app_number] => 09/151592 [patent_app_country] => US [patent_app_date] => 1998-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8287 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/355/06355859.pdf [firstpage_image] =>[orig_patent_app_number] => 09151592 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/151592
Interactions between genotype and diet in swine that prevent E. coli associated intestinal disease Sep 17, 1998 Issued
09/148275 GENE THERAPY FOR TREATMENT OF CANCER Sep 3, 1998 Abandoned
09/135849 GENE THERAPY FOR REGULATING SMOOTH MUSCLE CELL TONE Aug 17, 1998 Abandoned
Array ( [id] => 4374537 [patent_doc_number] => 06288301 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Treatment for juvenile diabetes' [patent_app_type] => 1 [patent_app_number] => 9/127028 [patent_app_country] => US [patent_app_date] => 1998-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 5783 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288301.pdf [firstpage_image] =>[orig_patent_app_number] => 127028 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/127028
Treatment for juvenile diabetes Jul 29, 1998 Issued
09/034099 PROTEIN BELONGING TO THE TNF SUPERFAMILY INVOLVED IN SIGNAL TRANSDUCTION, NUCLEIC ACIDS ENCODING SAME, AND METHODS OF USE THEREOF Mar 2, 1998 Abandoned
Array ( [id] => 668647 [patent_doc_number] => 07094889 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'AGE-1 polypeptides and related molecules and methods' [patent_app_type] => utility [patent_app_number] => 08/908453 [patent_app_country] => US [patent_app_date] => 1997-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 13585 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094889.pdf [firstpage_image] =>[orig_patent_app_number] => 08908453 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/908453
AGE-1 polypeptides and related molecules and methods Aug 6, 1997 Issued
Array ( [id] => 1500033 [patent_doc_number] => 06485964 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-26 [patent_title] => 'TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR' [patent_app_type] => B1 [patent_app_number] => 08/839605 [patent_app_country] => US [patent_app_date] => 1997-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12342 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/485/06485964.pdf [firstpage_image] =>[orig_patent_app_number] => 08839605 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/839605
TRANSGENIC MAMMALS LACKING EXPRESSION OF ERYTHROPOIETIN OR OF ERYTHROPOIETIN RECEPTOR, TRANSGENIC MAMMALS EXPRESSING CHIMERIC ERYTHROPOIETIN RECEPTORS, CONSTRUCTS FOR PRODUCING THE TRANSGENIC MAMMALS AND USES THEREFOR Apr 14, 1997 Issued
Array ( [id] => 515713 [patent_doc_number] => 07192933 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-03-20 [patent_title] => 'Use of a baculovirus to express an exogenous gene in a mammalian cell' [patent_app_type] => utility [patent_app_number] => 08/752032 [patent_app_country] => US [patent_app_date] => 1996-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 5252 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/192/07192933.pdf [firstpage_image] =>[orig_patent_app_number] => 08752032 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/752032
Use of a baculovirus to express an exogenous gene in a mammalian cell Nov 18, 1996 Issued
Menu